$400 Million is the total value of Capital Advantage, Inc.'s 81 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CAH | New | Cardinal Health Inc | $306,000 | – | 4,575 | +100.0% | 0.08% | – |
| KMB | New | Kimberly-Clark Corp | $294,000 | – | 2,497 | +100.0% | 0.07% | – |
| BSJK | New | Gugg. HY Bullet 2020 | $247,000 | – | 9,897 | +100.0% | 0.06% | – |
| DWDP | New | DowDuPont Inc | $236,000 | – | 3,405 | +100.0% | 0.06% | – |
| HRS | New | Harris Corp | $231,000 | – | 1,752 | +100.0% | 0.06% | – |
| VEA | New | Vanguard FTSE Developed Market | $222,000 | – | 5,105 | +100.0% | 0.06% | – |
| BMY | New | Bristol-Myers Squibb | $210,000 | – | 3,295 | +100.0% | 0.05% | – |
| CELG | New | Celgene Corp | $208,000 | – | 1,425 | +100.0% | 0.05% | – |
| HEDJ | New | WT Europe Hedged Equity | $202,000 | – | 3,121 | +100.0% | 0.05% | – |
| ATRS | New | Antares Pharma Inc | $110,000 | – | 34,000 | +100.0% | 0.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-10-30
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Microsoft Corp | 42 | Q2 2024 | 1.5% |
| Chevron Corp | 42 | Q2 2024 | 1.0% |
| Facebook Inc Class A | 42 | Q2 2024 | 1.3% |
| AT&T Inc | 42 | Q2 2024 | 0.6% |
| Pfizer Incorporated | 42 | Q2 2024 | 0.3% |
| Cisco Systems Inc | 42 | Q2 2024 | 0.3% |
| Verizon Communications Inc | 42 | Q2 2024 | 0.3% |
| Vanguard Dividend Appreciation ETF | 40 | Q2 2024 | 8.4% |
| Vanguard Mega Cap ETF | 39 | Q2 2024 | 5.9% |
| Schwab US Dividend Equity ETF | 38 | Q2 2024 | 6.2% |
View Capital Advantage, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-27 |
| 13F-HR | 2024-07-12 |
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-01-23 |
| 13F-HR | 2023-10-30 |
| 13F-HR | 2023-08-07 |
| 13F-HR | 2023-05-05 |
| 13F-HR | 2023-01-24 |
| 13F-HR | 2022-10-31 |
| 13F-HR | 2022-07-21 |
View Capital Advantage, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.